Outlook Therapeutics Inc
F:41ON
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
O
|
Outlook Therapeutics Inc
F:41ON
|
US |
|
Definity Financial Corp
F:XR6
|
CA |
|
Team17 Group PLC
F:2EC
|
UK |
|
Beowulf Mining PLC
LSE:BEM
|
UK |
|
Erste Group Bank AG
OTC:EBKDY
|
AT |
|
Unibail-Rodamco-Westfield SE
PAR:URW
|
FR |
|
V
|
VRG SA
WSE:VRG
|
PL |
|
Mesa Laboratories Inc
F:MLI
|
US |
Wall St Price Targets
41ON Price Targets Summary
Outlook Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for 41ON is 8.936 EUR with a low forecast of 0.804 EUR and a high forecast of 16.726 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 41ON's stock price target?
Price Target
8.936
EUR
According to Wall Street analysts, the average 1-year price target for 41ON is 8.936 EUR with a low forecast of 0.804 EUR and a high forecast of 16.726 EUR.
What is the Revenue forecast for Outlook Therapeutics Inc?
Projected CAGR
55%
Over the last 10 years, the compound annual growth rate for Revenue has been -12%. The projected CAGR for the next 8 years is 55%.
What is the Gross Profit forecast for Outlook Therapeutics Inc?
Projected CAGR
558%
The compound annual growth rate for Gross Profit over the next 3 years is 558%.
